Roles of vascular endothelial growth factor receptor 3 signaling in differentiation of mouse embryonic stem cell-derived vascular progenitor cells into endothelial cells - PubMed (original) (raw)
. 2005 Mar 15;105(6):2372-9.
doi: 10.1182/blood-2004-07-2547. Epub 2004 Nov 23.
Affiliations
- PMID: 15561887
- DOI: 10.1182/blood-2004-07-2547
Free article
Roles of vascular endothelial growth factor receptor 3 signaling in differentiation of mouse embryonic stem cell-derived vascular progenitor cells into endothelial cells
Hiroyuki Suzuki et al. Blood. 2005.
Free article
Abstract
Vascular endothelial growth factor receptor 2 (VEGFR2/Flk-1)-positive cells derived from embryonic stem (ES) cells serve as vascular progenitors, which differentiate into endothelial cells (ECs) in the presence of VEGF-A. VEGFR3/Flt-4 (fms-like tyrosine kinase 4) signaling is known to be important for the development of lymphatic endothelial cells (LECs). To elucidate the roles of VEGFR3 signaling in the differentiation of vascular progenitor cells into ECs, we introduced various types of VEGFR3 cDNAs into mouse ES cells. VEGF-C, a ligand for VEGFR2 and VEGFR3, stimulated the endothelial differentiation of the VEGFR2+ cells transfected with the VEGFR3 cDNA but not those transfected with kinase-negative mutants of VEGFR3. The VEGFR3-transfected ECs exhibited high expression levels of lymphatic vessel endothelial hyaluronan receptor-1 (LYVE-1), one of the markers of LECs, and showed efficient binding of hyaluronan. VEGF-C(C152S), which is able to activate VEGFR3 but not VEGFR2, failed to induce the endothelial differentiation of mock- and VEGFR3-transfected VEGFR2(+) cells, suggesting the essential role of VEGFR2 signaling for endothelial differentiation. Furthermore, kinase-negative mutants of VEGFR3 prevented the VEGF-C-mediated endothelial differentiation of the vascular progenitor cells. Thus, VEGFR2 signaling is required for the endothelial differentiation of mouse ES cells induced by VEGF-C, and VEGFR3 signaling may confer lymphatic endothelial-like phenotypes to ECs.
Similar articles
- Molecular controls of lymphatic VEGFR3 signaling.
Deng Y, Zhang X, Simons M. Deng Y, et al. Arterioscler Thromb Vasc Biol. 2015 Feb;35(2):421-9. doi: 10.1161/ATVBAHA.114.304881. Epub 2014 Dec 18. Arterioscler Thromb Vasc Biol. 2015. PMID: 25524775 Free PMC article. - VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling.
Heinolainen K, Karaman S, D'Amico G, Tammela T, Sormunen R, Eklund L, Alitalo K, Zarkada G. Heinolainen K, et al. Circ Res. 2017 Apr 28;120(9):1414-1425. doi: 10.1161/CIRCRESAHA.116.310477. Epub 2017 Mar 15. Circ Res. 2017. PMID: 28298294 Free PMC article. - [Effects of three inducing factors on differentiation of bone marrow derived mesenchymal stem cells into lymphatic endothelial cells].
Wang YH, Xue B. Wang YH, et al. Zhonghua Shao Shang Za Zhi. 2019 Feb 20;35(2):125-133. doi: 10.3760/cma.j.issn.1009-2587.2019.02.008. Zhonghua Shao Shang Za Zhi. 2019. PMID: 30798579 Chinese. - VEGFR signaling during lymphatic vascular development: From progenitor cells to functional vessels.
Secker GA, Harvey NL. Secker GA, et al. Dev Dyn. 2015 Mar;244(3):323-31. doi: 10.1002/dvdy.24227. Epub 2014 Dec 4. Dev Dyn. 2015. PMID: 25399804 Review. - Two Birds, One Stone: Double Hits on Tumor Growth and Lymphangiogenesis by Targeting Vascular Endothelial Growth Factor Receptor 3.
Hsu MC, Pan MR, Hung WC. Hsu MC, et al. Cells. 2019 Mar 21;8(3):270. doi: 10.3390/cells8030270. Cells. 2019. PMID: 30901976 Free PMC article. Review.
Cited by
- Three Dimensional Bioprinting for Hepatic Tissue Engineering: From In Vitro Models to Clinical Applications.
Kasturi M, Mathur V, Gadre M, Srinivasan V, Vasanthan KS. Kasturi M, et al. Tissue Eng Regen Med. 2024 Jan;21(1):21-52. doi: 10.1007/s13770-023-00576-3. Epub 2023 Oct 26. Tissue Eng Regen Med. 2024. PMID: 37882981 Free PMC article. Review. - Vascular endothelial growth factor-C and its receptor-3 signaling in tumorigenesis.
Vimalraj S, Hariprabu KNG, Rahaman M, Govindasami P, Perumal K, Sekaran S, Ganapathy D. Vimalraj S, et al. 3 Biotech. 2023 Oct;13(10):326. doi: 10.1007/s13205-023-03719-4. Epub 2023 Sep 1. 3 Biotech. 2023. PMID: 37663750 Free PMC article. Review. - Lymphatic Tissue and Organ Engineering for In Vitro Modeling and In Vivo Regeneration.
Kolarzyk AM, Wong G, Lee E. Kolarzyk AM, et al. Cold Spring Harb Perspect Med. 2022 Mar 14;12(9):a041169. doi: 10.1101/cshperspect.a041169. Online ahead of print. Cold Spring Harb Perspect Med. 2022. PMID: 35288402 Free PMC article. - The physiological and pathological functions of VEGFR3 in cardiac and lymphatic development and related diseases.
Monaghan RM, Page DJ, Ostergaard P, Keavney BD. Monaghan RM, et al. Cardiovasc Res. 2021 Jul 7;117(8):1877-1890. doi: 10.1093/cvr/cvaa291. Cardiovasc Res. 2021. PMID: 33067626 Free PMC article. Review. - Integrating Biological Advances Into the Clinical Management of Breast Cancer Related Lymphedema.
Invernizzi M, Lopez G, Michelotti A, Venetis K, Sajjadi E, De Mattos-Arruda L, Ghidini M, Runza L, de Sire A, Boldorini R, Fusco N. Invernizzi M, et al. Front Oncol. 2020 Apr 2;10:422. doi: 10.3389/fonc.2020.00422. eCollection 2020. Front Oncol. 2020. PMID: 32300557 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous